Comprehensive Inventory
Browse by expertise area | Browse by support scope | CI background
The purpose of this Comprehensive Inventory (CI) is to assist European academic drug developers in finding support on regulatory affairs. The inventory lists various support services provided by national competent authorities, public actors and private entities.
You can sort the tables below by selecting one of the categories in the top row. This will help you to in find specific information based on country, expertise area and support scope. Provider profiles can be downloaded in PDF format, just click the respective link to view and/or download.
Please note that some providers are active across Europe and may be listed under their country of origin and / or under "Europe". Some providers offer services to a specific language area and are listed under more than one country.
Disclaimer: The STARS consortium is not responsible for the content of the CI. The listed services can be subject to a fee; please contact the service provider for more information.
Listing by Expertise Area
| Country | Provider Type | Expertise | Provider Details |
|---|---|---|---|
| Austria | Public Actor | Biomarkers | Medical University Innsbruck |
| Austria | Public Actor | Chemicals | Medical University Innsbruck |
| Austria | Public Actor | Drug repurposing | Medical University Innsbruck |
| Austria | Public Actor | e/m-health | Medical University Innsbruck |
| Austria | Public Actor | Medical devices | Medical University Innsbruck |
| Austria | Public Actor | Pediatric studies | Medical University Innsbruck |
| Austria | Public Actor | ATMPs | Medical University of Graz |
| Austria | Public Actor | Biologicals | Medical University of Graz |
| Austria | Public Actor | Chemicals | Medical University of Graz |
| Austria | Public Actor | Drug repurposing | Medical University of Graz |
| Austria | Public Actor | Medical devices | Medical University of Graz |
| Austria | National Competent Authority | ATMPs | BASG / AGES |
| Austria | National Competent Authority | Biologicals | BASG / AGES |
| Austria | National Competent Authority | Biomarkers | BASG / AGES |
| Austria | National Competent Authority | Chemicals | BASG / AGES |
| Austria | National Competent Authority | Drug repurposing | BASG / AGES |
| Austria | National Competent Authority | Pediatric studies | BASG / AGES |
| Austria | National Competent Authority | Statistics | BASG / AGES |
| Belgium | Public Actor | Chemicals | University of Liège |
| Belgium | Public Actor | Statistics | University of Liège |
| Belgium | Public Actor | Biologicals | UZ Brussel |
| Belgium | Public Actor | Diagnostics | UZ Brussel |
| Belgium | Public Actor | ATMPs | Antwerp University Hospital |
| Belgium | Public Actor | Biologicals | Antwerp University Hospital |
| Belgium | Public Actor | Biomarkers | Antwerp University Hospital |
| Belgium | Public Actor | Chemicals | Antwerp University Hospital |
| Belgium | Public Actor | Diagnostics | Antwerp University Hospital |
| Belgium | Public Actor | Drug repurposing | Antwerp University Hospital |
| Belgium | Public Actor | e/m-health | Antwerp University Hospital |
| Belgium | Public Actor | Medical devices | Antwerp University Hospital |
| Belgium | Public Actor | Pediatric studies | Antwerp University Hospital |
| Belgium | Public Actor | Statistics | Antwerp University Hospital |
| Belgium | National Competent Authority | ATMPs | FAMHP |
| Belgium | National Competent Authority | Biologicals | FAMHP |
| Belgium | National Competent Authority | Biomarkers | FAMHP |
| Belgium | National Competent Authority | Chemicals | FAMHP |
| Belgium | National Competent Authority | Drug-device combination products | FAMHP |
| Belgium | National Competent Authority | Drug repurposing | FAMHP |
| Belgium | National Competent Authority | Pediatric studies | FAMHP |
| Belgium | National Competent Authority | Statistics | FAMHP |
| Croatia | Public Actor | ATMPs | University Hospital Center Zagreb |
| Croatia | Public Actor | Biomarkers | University Hospital Center Zagreb |
| Croatia | Public Actor | Diagnostics | University Hospital Center Zagreb |
| Croatia | Public Actor | e/m-health | University Hospital Center Zagreb |
| Croatia | Public Actor | Medical devices | University Hospital Center Zagreb |
| Croatia | Public Actor | Pediatric studies | University Hospital Center Zagreb |
| Croatia | National Competent Authority | ATMPs | HALMED |
| Croatia | National Competent Authority | Biologicals | HALMED |
| Croatia | National Competent Authority | Chemicals | HALMED |
| Croatia | National Competent Authority | Drug repurposing | HALMED |
| Croatia | National Competent Authority | Medical devices | HALMED |
| Croatia | National Competent Authority | Pediatric studies | HALMED |
| Croatia | National Competent Authority | Statistics | HALMED |
| Czech Republic | Public Actor | ATMPs | University Hospital Hradec Králové |
| Czech Republic | Public Actor | Chemicals | University Hospital Hradec Králové |
| Czech Republic | Public Actor | Diagnostics | University Hospital Hradec Králové |
| Czech Republic | Public Actor | Medical devices | University Hospital Hradec Králové |
| Czech Republic | Public Actor | ATMPs | PharmAround |
| Czech Republic | Public Actor | e/m-health | PharmAround |
| Czech Republic | Public Actor | Medical devices | PharmAround |
| Czech Republic | Public Actor | Pediatric studies | PharmAround |
| Czech Republic | Public Actor | Statistics | PharmAround |
| Czech Republic | Public Actor | ATMPs | Czech Clinical Research Infrastructure Network |
| Czech Republic | Public Actor | Biologicals | Czech Clinical Research Infrastructure Network |
| Czech Republic | Public Actor | Diagnostics | Czech Clinical Research Infrastructure Network |
| Czech Republic | Public Actor | Drug repurposing | Czech Clinical Research Infrastructure Network |
| Czech Republic | Public Actor | Medical devices | Czech Clinical Research Infrastructure Network |
| Czech Republic | Public Actor | Pediatric studies | Czech Clinical Research Infrastructure Network |
| Czech Republic | Public Actor | Statistics | Czech Clinical Research Infrastructure Network |
| Czech Republic | National Competent Authority | ATMPs | SUKL |
| Czech Republic | National Competent Authority | Biologicals | SUKL |
| Czech Republic | National Competent Authority | Chemicals | SUKL |
| Czech Republic | National Competent Authority | Drug repurposing | SUKL |
| Czech Republic | National Competent Authority | Medical devices | SUKL |
| Czech Republic | National Competent Authority | Pediatric studies | SUKL |
| Czech Republic | National Competent Authority | Statistics | SUKL |
| Estonia | Public Actor | Not specified | University of Tartu |
| Estonia | Public Actor | Pediatric studies | University of Tartu |
| Estonia | Public Actor | Biologicals | North Estonia Medical Center |
| Estonia | Public Actor | Biomarkers | North Estonia Medical Center |
| Estonia | Public Actor | Chemicals | North Estonia Medical Center |
| Estonia | Public Actor | Diagnostics | North Estonia Medical Center |
| Estonia | Public Actor | Drug repurposing | North Estonia Medical Center |
| Estonia | Public Actor | e/m-health | North Estonia Medical Center |
| Estonia | Public Actor | Medical devices | North Estonia Medical Center |
| Estonia | Public Actor | Statistics | North Estonia Medical Center |
| Europe | Public Actor | Chemicals | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Europe | Public Actor | Drug repurposing | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Europe | Public Actor | Biologicals | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Europe | Public Actor | ATMPs | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Europe | Public Actor | e/m-health | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Europe | Public Actor | Medical devices | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Europe | Public Actor | Statistics | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Europe | Public Actor | Diagnostics | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Europe | Public Actor | Pediatric studies | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Europe | Public Actor | Not specified | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Europe | Public Actor | ATMPs | MRC Regulatory Support Centre |
| Europe | Public Actor | Diagnostics | MRC Regulatory Support Centre |
| Europe | Public Actor | Medical devices | MRC Regulatory Support Centre |
| Europe | Public Actor | Medical devices | EVICR.net |
| Europe | Public Actor | Not specified | EVICR.net |
| Europe | Public Actor | ATMPs | EATRIS |
| Europe | Public Actor | Biologicals | EATRIS |
| Europe | Public Actor | Biomarkers | EATRIS |
| Europe | Public Actor | Chemicals | EATRIS |
| Europe | Public Actor | Diagnostics | EATRIS |
| Europe | Public Actor | Drug repurposing | EATRIS |
| Europe | Public Actor | e/m-health | EATRIS |
| Europe | Public Actor | Medical devices | EATRIS |
| Europe | Public Actor | Pediatric studies | EATRIS |
| Europe | Public Actor | Statistics | EATRIS |
| Europe | Public Actor | ATMPs | Research Quality Association |
| Europe | Public Actor | Chemicals | Research Quality Association |
| Europe | Public Actor | e/m-health | Research Quality Association |
| Europe | Public Actor | Medical devices | Research Quality Association |
| Europe | Public Actor | Statistics | Research Quality Association |
| Europe | Private Actor | ATMPs | Pharmahungary |
| Europe | Private Actor | Biologicals | Pharmahungary |
| Europe | Private Actor | Biomarkers | Pharmahungary |
| Europe | Private Actor | Chemicals | Pharmahungary |
| Europe | Private Actor | Diagnostics | Pharmahungary |
| Europe | Private Actor | Drug repurposing | Pharmahungary |
| Europe | Private Actor | Medical devices | Pharmahungary |
| Europe | Private Actor | Statistics | Pharmahungary |
| Europe | Public Actor | ATMPs | European Centre for Clinical Research Training |
| Europe | Public Actor | Biologicals | European Centre for Clinical Research Training |
| Europe | Public Actor | Drug repurposing | European Centre for Clinical Research Training |
| Europe | Public Actor | e/m-health | European Centre for Clinical Research Training |
| Europe | Public Actor | Medical devices | European Centre for Clinical Research Training |
| Europe | Public Actor | Pediatric studies | European Centre for Clinical Research Training |
| Europe | Public Actor | Statistics | European Centre for Clinical Research Training |
| Europe | Public Actor | ATMPs | HRB Clinical Research Facility Galway |
| Europe | Public Actor | Biologicals | HRB Clinical Research Facility Galway |
| Europe | Public Actor | Biomarkers | HRB Clinical Research Facility Galway |
| Europe | Public Actor | Diagnostics | HRB Clinical Research Facility Galway |
| Europe | Public Actor | e/m-health | HRB Clinical Research Facility Galway |
| Europe | Public Actor | Medical devices | HRB Clinical Research Facility Galway |
| Europe | Public Actor | Statistics | HRB Clinical Research Facility Galway |
| Europe | Public Actor | Ethical aspects | European Forum for Good Clinical Practice |
| Europe | Public Actor | Medical devices | European Forum for Good Clinical Practice |
| Europe | Public Actor | Pediatric studies | European Forum for Good Clinical Practice |
| Europe | Public Actor | ATMPs | European Clinical Research Infrastructure Network |
| Europe | Public Actor | Biomarkers | European Clinical Research Infrastructure Network |
| Europe | Public Actor | Chemicals | European Clinical Research Infrastructure Network |
| Europe | Public Actor | Diagnostics | European Clinical Research Infrastructure Network |
| Europe | Public Actor | Drug repurposing | European Clinical Research Infrastructure Network |
| Europe | Public Actor | Medical devices | European Clinical Research Infrastructure Network |
| Europe | Public Actor | Pediatric studies | European Clinical Research Infrastructure Network |
| Europe | Public Actor | ATMPs | Institute for Interdisciplinary Innovation in healthcare |
| Europe | Public Actor | Biologicals | Institute for Interdisciplinary Innovation in healthcare |
| Europe | Public Actor | Biomarkers | Institute for Interdisciplinary Innovation in healthcare |
| Europe | Public Actor | Chemicals | Institute for Interdisciplinary Innovation in healthcare |
| Europe | Public Actor | Diagnostics | Institute for Interdisciplinary Innovation in healthcare |
| Europe | Public Actor | Drug repurposing | Institute for Interdisciplinary Innovation in healthcare |
| Europe | Public Actor | e/m-health | Institute for Interdisciplinary Innovation in healthcare |
| Europe | Public Actor | Medical devices | Institute for Interdisciplinary Innovation in healthcare |
| Europe | Public Actor | Pediatric studies | Institute for Interdisciplinary Innovation in healthcare |
| Europe | Public Actor | Statistics | Institute for Interdisciplinary Innovation in healthcare |
| Europe | Public Actor | ATMPs | International Clinical Trial Center Network |
| Europe | Public Actor | Biologicals | International Clinical Trial Center Network |
| Europe | Public Actor | Biomarkers | International Clinical Trial Center Network |
| Europe | Public Actor | Chemicals | International Clinical Trial Center Network |
| Europe | Public Actor | Diagnostics | International Clinical Trial Center Network |
| Europe | Public Actor | Drug repurposing | International Clinical Trial Center Network |
| Europe | Public Actor | e/m-health | International Clinical Trial Center Network |
| Europe | Public Actor | Medical devices | International Clinical Trial Center Network |
| Europe | Public Actor | Pediatric studies | International Clinical Trial Center Network |
| Europe | Public Actor | Statistics | International Clinical Trial Center Network |
| Finland | Public Actor | Chemicals | University of Eastern Finland |
| Finland | Public Actor | ATMPs | Northern Savo Hospital District Municipal Federation |
| Finland | Public Actor | Biologicals | Northern Savo Hospital District Municipal Federation |
| Finland | Public Actor | Biomarkers | Northern Savo Hospital District Municipal Federation |
| Finland | Public Actor | Diagnostics | Northern Savo Hospital District Municipal Federation |
| Finland | Public Actor | Drug repurposing | Northern Savo Hospital District Municipal Federation |
| Finland | Public Actor | e/m-health | Northern Savo Hospital District Municipal Federation |
| Finland | Public Actor | Medical devices | Northern Savo Hospital District Municipal Federation |
| Finland | Public Actor | Pediatric studies | Northern Savo Hospital District Municipal Federation |
| Finland | Public Actor | Statistics | Northern Savo Hospital District Municipal Federation |
| Finland | National Competent Authority | ATMPs | FIMEA |
| Finland | National Competent Authority | Biologicals | FIMEA |
| Finland | National Competent Authority | Biomarkers | FIMEA |
| Finland | National Competent Authority | Chemicals | FIMEA |
| Finland | National Competent Authority | Diagnostics | FIMEA |
| Finland | National Competent Authority | Drug repurposing | FIMEA |
| Finland | National Competent Authority | Medical devices | FIMEA |
| Finland | National Competent Authority | Pediatric studies | FIMEA |
| Finland | National Competent Authority | Statistics | FIMEA |
| France | Public Actor | Biologicals | CHU Grenoble Alpes |
| France | Public Actor | Biomarkers | CHU Grenoble Alpes |
| France | Public Actor | Chemicals | CHU Grenoble Alpes |
| France | Public Actor | Medical devices | CHU Grenoble Alpes |
| France | Public Actor | Pediatric studies | CHU Grenoble Alpes |
| France | Public Actor | Statistics | CHU Grenoble Alpes |
| France | Public Actor | ATMPs | AP-HP |
| France | Public Actor | Biologicals | AP-HP |
| France | Public Actor | Biomarkers | AP-HP |
| France | Public Actor | Diagnostics | AP-HP |
| France | Public Actor | Drug repurposing | AP-HP |
| France | Public Actor | e/m-health | AP-HP |
| France | Public Actor | Medical devices | AP-HP |
| France | Public Actor | Pediatric studies | AP-HP |
| France | Public Actor | Statistics | AP-HP |
| France | Public Actor | Biologicals | Rothschild Foundation Hospital |
| France | Public Actor | Biomarkers | Rothschild Foundation Hospital |
| France | Public Actor | Drug repurposing | Rothschild Foundation Hospital |
| France | Public Actor | Medical devices | Rothschild Foundation Hospital |
| France | Public Actor | Pediatric studies | Rothschild Foundation Hospital |
| France | Public Actor | Statistics | Rothschild Foundation Hospital |
| France | Public Actor | ATMPs | CHU Amiens Picardie |
| France | Public Actor | Biomarkers | CHU Amiens Picardie |
| France | Public Actor | e/m-health | CHU Amiens Picardie |
| France | Public Actor | Pediatric studies | CHU Amiens Picardie |
| France | Public Actor | Statistics | CHU Amiens Picardie |
| Germany | Public Actor | Chemicals | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Germany | Public Actor | Drug repurposing | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Germany | Public Actor | Biologicals | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Germany | Public Actor | ATMPs | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Germany | Public Actor | e/m-health | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Germany | Public Actor | Medical devices | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Germany | Public Actor | Statistics | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Germany | Public Actor | Diagnostics | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Germany | Public Actor | Pediatric studies | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Germany | Public Actor | Not specified | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Germany | Public Actor | ATMPs | Technical University Munich |
| Germany | Public Actor | Biologicals | Technical University Munich |
| Germany | Public Actor | Biomarkers | Technical University Munich |
| Germany | Public Actor | Chemicals | Technical University Munich |
| Germany | Public Actor | Diagnostics | Technical University Munich |
| Germany | Public Actor | Drug repurposing | Technical University Munich |
| Germany | Public Actor | Medical devices | Technical University Munich |
| Germany | Public Actor | Pediatric studies | Technical University Munich |
| Germany | Public Actor | Statistics | Technical University Munich |
| Germany | Public Actor | Biologicals | Center for Clinical Trials Tuebingen |
| Germany | Public Actor | Chemicals | Center for Clinical Trials Tuebingen |
| Germany | Public Actor | Medical devices | Center for Clinical Trials Tuebingen |
| Germany | Public Actor | Biomarkers | Medical University Innsbruck |
| Germany | Public Actor | Chemicals | Medical University Innsbruck |
| Germany | Public Actor | Drug repurposing | Medical University Innsbruck |
| Germany | Public Actor | e/m-health | Medical University Innsbruck |
| Germany | Public Actor | Medical devices | Medical University Innsbruck |
| Germany | Public Actor | Pediatric studies | Medical University Innsbruck |
| Germany | Public Actor | ATMPs | Clinical Trial Centre Leipzig |
| Germany | Public Actor | Biologicals | Clinical Trial Centre Leipzig |
| Germany | Public Actor | Chemicals | Clinical Trial Centre Leipzig |
| Germany | Public Actor | Drug repurposing | Clinical Trial Centre Leipzig |
| Germany | Public Actor | Medical devices | Clinical Trial Centre Leipzig |
| Germany | Public Actor | Pediatric studies | Clinical Trial Centre Leipzig |
| Germany | Public Actor | Statistics | Clinical Trial Centre Leipzig |
| Germany | Public Actor | Chemicals | The Philipps University Marburg |
| Germany | Public Actor | Diagnostics | The Philipps University Marburg |
| Germany | Public Actor | e/m-health | The Philipps University Marburg |
| Germany | Public Actor | Medical devices | The Philipps University Marburg |
| Germany | Public Actor | Statistics | The Philipps University Marburg |
| Germany | Public Actor | ATMPs | Association for Applied Human Pharmacology |
| Germany | Public Actor | Biologicals | Association for Applied Human Pharmacology |
| Germany | Public Actor | Biomarkers | Association for Applied Human Pharmacology |
| Germany | Public Actor | Drug repurposing | Association for Applied Human Pharmacology |
| Germany | Public Actor | Pediatric studies | Association for Applied Human Pharmacology |
| Germany | Public Actor | Statistics | Association for Applied Human Pharmacology |
| Germany | Public Actor | Quality | Association for Applied Human Pharmacology |
| Germany | Public Actor | ATMPs | Network of Coordinating Centers for Clinical Trials |
| Germany | Public Actor | Biomarkers | Network of Coordinating Centers for Clinical Trials |
| Germany | Public Actor | Diagnostics | Network of Coordinating Centers for Clinical Trials |
| Germany | Public Actor | Medical devices | Network of Coordinating Centers for Clinical Trials |
| Germany | Public Actor | Statistics | Network of Coordinating Centers for Clinical Trials |
| Germany | Public Actor | Chemicals | SZB - Clinical Study Core Unit Bonn |
| Germany | Public Actor | Drug repurposing | SZB - Clinical Study Core Unit Bonn |
| Germany | Public Actor | Medical devices | SZB - Clinical Study Core Unit Bonn |
| Germany | Public Actor | Statistics | SZB - Clinical Study Core Unit Bonn |
| Germany | National Competent Authority | Biologicals | BfArM |
| Germany | National Competent Authority | Biomarkers | BfArM |
| Germany | National Competent Authority | Chemicals | BfArM |
| Germany | National Competent Authority | Diagnostics | BfArM |
| Germany | National Competent Authority | Drug repurposing | BfArM |
| Germany | National Competent Authority | e/m-health | BfArM |
| Germany | National Competent Authority | Medical devices | BfArM |
| Germany | National Competent Authority | Pediatric studies | BfArM |
| Germany | National Competent Authority | Statistics | BfArM |
| Germany | National Competent Authority | Biologicals | Paul Ehrlich Institut |
| Germany | National Competent Authority | ATMPs | Paul Ehrlich Institut |
| Germany | National Competent Authority | Satistics | Paul Ehrlich Institut |
| Germany | National Competent Authority | Pedriatic Studies | Paul Ehrlich Institut |
| Germany | National Competent Authority | IVDs, Blood Products | Paul Ehrlich Institut |
| Hungary | Public Actor | ATMPs | Semmelweis University |
| Hungary | Public Actor | Biologicals | Semmelweis University |
| Hungary | Public Actor | Biomarkers | Semmelweis University |
| Hungary | Public Actor | Chemicals | Semmelweis University |
| Hungary | Public Actor | Diagnostics | Semmelweis University |
| Hungary | Public Actor | Drug repurposing | Semmelweis University |
| Hungary | Public Actor | e/m-health | Semmelweis University |
| Hungary | Public Actor | Medical devices | Semmelweis University |
| Hungary | Public Actor | Pediatric studies | Semmelweis University |
| Hungary | Public Actor | Statistics | Semmelweis University |
| Hungary | Public Actor | Chemicals | University of Pécs Coordination Center for Clinical Trials |
| Hungary | Public Actor | Diagnostics | University of Pécs Coordination Center for Clinical Trials |
| Hungary | Public Actor | Medical devices | University of Pécs Coordination Center for Clinical Trials |
| Hungary | Public Actor | Pediatric studies | University of Pécs Coordination Center for Clinical Trials |
| Hungary | National Competent Authority | ATMPs | OGYÉI |
| Hungary | National Competent Authority | Biologicals | OGYÉI |
| Hungary | National Competent Authority | Chemicals | OGYÉI |
| Hungary | National Competent Authority | Medical devices | OGYÉI |
| Hungary | National Competent Authority | Pediatric studies | OGYÉI |
| Ireland | Public Actor | ATMPs | University College Cork |
| Ireland | Public Actor | Biologicals | University College Cork |
| Ireland | Public Actor | Biomarkers | University College Cork |
| Ireland | Public Actor | Chemicals | University College Cork |
| Ireland | Public Actor | e/m-health | University College Cork |
| Ireland | Public Actor | Medical devices | University College Cork |
| Ireland | Public Actor | Pediatric studies | University College Cork |
| Ireland | Public Actor | Statistics | University College Cork |
| Ireland | Public Actor | Not specified | Royal College of Surgeons in Ireland |
| Ireland | Public Actor | ATMPs | Health Research Board Clinical Research Coordination Ireland |
| Ireland | Public Actor | Biologicals | Health Research Board Clinical Research Coordination Ireland |
| Ireland | Public Actor | Biomarkers | Health Research Board Clinical Research Coordination Ireland |
| Ireland | Public Actor | Chemicals | Health Research Board Clinical Research Coordination Ireland |
| Ireland | Public Actor | Diagnostics | Health Research Board Clinical Research Coordination Ireland |
| Ireland | Public Actor | Drug repurposing | Health Research Board Clinical Research Coordination Ireland |
| Ireland | Public Actor | Medical devices | Health Research Board Clinical Research Coordination Ireland |
| Ireland | Public Actor | Pediatric studies | Health Research Board Clinical Research Coordination Ireland |
| Ireland | Public Actor | Statistics | Health Research Board Clinical Research Coordination Ireland |
| Ireland | Public Actor | Biomarkers | Cancer Trials Ireland |
| Ireland | Public Actor | Chemicals | Cancer Trials Ireland |
| Ireland | Public Actor | Pediatric studies | Cancer Trials Ireland |
| Ireland | Public Actor | Statistics | Cancer Trials Ireland |
| Ireland | National Competent Authority | ATMPs | HPRA |
| Ireland | National Competent Authority | Biologicals | HPRA |
| Ireland | National Competent Authority | Chemicals | HPRA |
| Ireland | National Competent Authority | Diagnostics | HPRA |
| Ireland | National Competent Authority | Drug repurposing | HPRA |
| Ireland | National Competent Authority | Medical devices | HPRA |
| Italy | Public Actor | ATMPs | Sant’Orsola-Malpighi Hospital Bologna |
| Italy | Public Actor | Biologicals | Sant’Orsola-Malpighi Hospital Bologna |
| Italy | Public Actor | Chemicals | Sant’Orsola-Malpighi Hospital Bologna |
| Italy | Public Actor | Diagnostics | Sant’Orsola-Malpighi Hospital Bologna |
| Italy | Public Actor | Drug repurposing | Sant’Orsola-Malpighi Hospital Bologna |
| Italy | Public Actor | e/m-health | Sant’Orsola-Malpighi Hospital Bologna |
| Italy | Public Actor | Medical devices | Sant’Orsola-Malpighi Hospital Bologna |
| Italy | Public Actor | Pediatric studies | Sant’Orsola-Malpighi Hospital Bologna |
| Italy | Public Actor | Statistics | Sant’Orsola-Malpighi Hospital Bologna |
| Italy | Public Actor | Biologicals | Istituto Europeo di Oncologia |
| Italy | Public Actor | Drug repurposing | Istituto Europeo di Oncologia |
| Italy | Public Actor | Medical devices | Istituto Europeo di Oncologia |
| Italy | Public Actor | Not specified | Istituto Nazionale Tumori |
| Latvia | Public Actor | Biomarkers | University of Latvia |
| Latvia | Public Actor | Diagnostics | University of Latvia |
| Latvia | Public Actor | Drug repurposing | University of Latvia |
| Latvia | Public Actor | Pediatric studies | University of Latvia |
| Latvia | Public Actor | Statistics | University of Latvia |
| Latvia | Public Actor | Ethical aspects | Pauls Stradins Clinical University Hospital |
| Latvia | Public Actor | Legal matters | Pauls Stradins Clinical University Hospital |
| Latvia | Public Actor | Medical devices | Pauls Stradins Clinical University Hospital |
| Malta | National Competent Authority | Chemicals | Medicines Authority |
| Netherlands | National Competent Authority | ATMPs | Medicines Evaluation Board |
| Netherlands | National Competent Authority | Biologicals | Medicines Evaluation Board |
| Netherlands | National Competent Authority | Biomarkers | Medicines Evaluation Board |
| Netherlands | National Competent Authority | Chemicals | Medicines Evaluation Board |
| Netherlands | National Competent Authority | Diagnostics | Medicines Evaluation Board |
| Netherlands | National Competent Authority | Drug repurposing | Medicines Evaluation Board |
| Netherlands | National Competent Authority | e/m-health | Medicines Evaluation Board |
| Netherlands | National Competent Authority | Medical devices | Medicines Evaluation Board |
| Netherlands | National Competent Authority | Pediatric studies | Medicines Evaluation Board |
| Netherlands | National Competent Authority | Statistics | Medicines Evaluation Board |
| Netherlands | Public Actor | Ethical aspects | ELSI Servicedesk |
| Netherlands | Public Actor | Societal aspects | ELSI Servicedesk |
| Netherlands | Public Actor | Legal matters | ELSI Servicedesk |
| Netherlands | Public Actor | ATMPs | Regulatory Science Network Netherlands |
| Netherlands | Public Actor | Biologicals | Regulatory Science Network Netherlands |
| Netherlands | Public Actor | Biomarkers | Regulatory Science Network Netherlands |
| Netherlands | Public Actor | Drug repurposing | Regulatory Science Network Netherlands |
| Netherlands | Public Actor | e/m-health | Regulatory Science Network Netherlands |
| Netherlands | Public Actor | Pediatric studies | Regulatory Science Network Netherlands |
| Netherlands | Public Actor | Statistics | Regulatory Science Network Netherlands |
| Norway | National Competent Authority | ATMPs | Norwegian Medicines Agency |
| Norway | National Competent Authority | Biologicals | Norwegian Medicines Agency |
| Norway | National Competent Authority | Biomarkers | Norwegian Medicines Agency |
| Norway | National Competent Authority | Chemicals | Norwegian Medicines Agency |
| Norway | National Competent Authority | Drug repurposing | Norwegian Medicines Agency |
| Norway | National Competent Authority | Medical devices | Norwegian Medicines Agency |
| Norway | National Competent Authority | Pedriatic studies | Norwegian Medicines Agency |
| Portugal | National Competent Agency | Chemicals | Inframed IP |
| Portugal | National Competent Agency | Drug Repurposing | Inframed IP |
| Portugal | National Competent Agency | Biologicals | Inframed IP |
| Portugal | National Competent Agency | e/m health | Inframed IP |
| Portugal | National Competent Agency | Medical devices | Inframed IP |
| Portugal | National Competent Agency | Statistics | Inframed IP |
| Portugal | National Competent Agency | Diagnostics | Inframed IP |
| Portugal | National Competent Agency | Biomarkers | Inframed IP |
| Portugal | National Competent Agency | Pediatrics | Inframed IP |
| Portugal | National Competent Agency | ATMPs | Inframed IP |
| Portugal | Public Actor | Diagnostics | 2CA-Braga |
| Portugal | Public Actor | Drug repurposing | 2CA-Braga |
| Portugal | Public Actor | Medical devices | 2CA-Braga |
| Portugal | Public Actor | Statistics | 2CA-Braga |
| Portugal | Public Actor | Biologicals | Portuguese Oncology Institute |
| Portugal | Public Actor | Biomarkers | Portuguese Oncology Institute |
| Portugal | Public Actor | Chemicals | Portuguese Oncology Institute |
| Portugal | Public Actor | Diagnostics | Portuguese Oncology Institute |
| Portugal | Public Actor | Pediatric studies | Portuguese Oncology Institute |
| Portugal | Public Actor | Statistics | Portuguese Oncology Institute |
| Slovakia | Public Actor | Biologicals | Pavol Jozef Safarik University in Kosice |
| Slovakia | Public Actor | Chemicals | Pavol Jozef Safarik University in Kosice |
| Slovakia | Public Actor | Pediatric studies | Pavol Jozef Safarik University in Kosice |
| Spain | Public Actor | Pediatric studies | RECLIP |
| Spain | Public Actor | ATMPs | CIBER |
| Spain | Public Actor | Drug repurposing | CIBER |
| Spain | Public Actor | ATMPs | Vall d’Hebron Research Institut |
| Spain | Public Actor | Biologicals | Vall d’Hebron Research Institut |
| Spain | Public Actor | Diagnostics | Vall d’Hebron Research Institut |
| Spain | Public Actor | Medical devices | Vall d’Hebron Research Institut |
| Spain | Public Actor | Pediatric studies | Vall d’Hebron Research Institut |
| Spain | Public Actor | Statistics | Vall d’Hebron Research Institut |
| Spain | National Competent Authority | ATMPs | AEMPS |
| Spain | National Competent Authority | Biologicals | AEMPS |
| Spain | National Competent Authority | Biomarkers | AEMPS |
| Spain | National Competent Authority | Chemicals | AEMPS |
| Spain | National Competent Authority | Diagnostics | AEMPS |
| Spain | National Competent Authority | Drug repurposing | AEMPS |
| Spain | National Competent Authority | e/m-health | AEMPS |
| Spain | National Competent Authority | Medical devices | AEMPS |
| Spain | National Competent Authority | Pediatric studies | AEMPS |
| Spain | National Competent Authority | Statistics | AEMPS |
| Sweden | National Competent Authority | ATMPs | Swedish Medical Products Agency |
| Sweden | National Competent Authority | Biologicals | Swedish Medical Products Agency |
| Sweden | National Competent Authority | Biomarkers | Swedish Medical Products Agency |
| Sweden | National Competent Authority | Chemicals | Swedish Medical Products Agency |
| Sweden | National Competent Authority | Drug repurposing | Swedish Medical Products Agency |
| Sweden | National Competent Authority | Pedriatic studies | Swedish Medical Products Agency |
| Sweden | National Competent Authority | Statistics | Swedish Medical Products Agency |
| Switzerland | Public Actor | Biomarkers | Medical University Innsbruck |
| Switzerland | Public Actor | Chemicals | Medical University Innsbruck |
| Switzerland | Public Actor | Drug repurposing | Medical University Innsbruck |
| Switzerland | Public Actor | e/m-health | Medical University Innsbruck |
| Switzerland | Public Actor | Medical devices | Medical University Innsbruck |
| Switzerland | Public Actor | Pediatric studies | Medical University Innsbruck |
| Switzerland | Public Actor | ATMPs | Clinical Trails Center Zurich |
| Switzerland | Public Actor | Diagnostics | Clinical Trails Center Zurich |
| Switzerland | Public Actor | Drug repurposing | Clinical Trails Center Zurich |
| Switzerland | Public Actor | Medical devices | Clinical Trails Center Zurich |
| Switzerland | Public Actor | Chemicals | Clinical Trails Center Zurich |
| UK | National Competent Authority | ATMPs | MHRA innovation office |
| UK | National Competent Authority | Biologicals | MHRA innovation office |
| UK | National Competent Authority | Biomarkers | MHRA innovation office |
| UK | National Competent Authority | Diagnostics | MHRA innovation office |
| UK | National Competent Authority | Drug repurposing | MHRA innovation office |
| UK | National Competent Authority | e/m-health | MHRA innovation office |
| UK | National Competent Authority | Medical devices | MHRA innovation office |
| UK | National Competent Authority | Pediatric studies | MHRA innovation office |
| UK | National Competent Authority | Statistics | MHRA innovation office |
| UK | Public Actor | ATMPs | University of Oxford |
| UK | Public Actor | Biologicals | University of Oxford |
| UK | Public Actor | Biomarkers | University of Oxford |
| UK | Public Actor | Chemicals | University of Oxford |
| UK | Public Actor | Drug repurposing | University of Oxford |
| UK | Public Actor | e/m-health | University of Oxford |
| UK | Public Actor | Pediatric studies | University of Oxford |
| UK | Public Actor | ATMPs | The Newcastle upon Tyne Hospitals NHS Foundation Trust |
| UK | Public Actor | Drug repurposing | The Newcastle upon Tyne Hospitals NHS Foundation Trust |
| UK | Public Actor | Medical devices | The Newcastle upon Tyne Hospitals NHS Foundation Trust |
| UK | Public Actor | Pediatric studies | The Newcastle upon Tyne Hospitals NHS Foundation Trust |
Listing by Support Scope
| Country | Provider Type | Support Activity | Provider Details |
|---|---|---|---|
| Austria | Public Actor | Assistance in clinical trial application | Medical University Innsbruck |
| Austria | Public Actor | GCP | Medical University Innsbruck |
| Austria | Public Actor | Phase I | Medical University Innsbruck |
| Austria | Public Actor | Phase II-III | Medical University Innsbruck |
| Austria | Public Actor | Phase IV | Medical University Innsbruck |
| Austria | Public Actor | Assistance in clinical trial application | Medical University of Graz |
| Austria | Public Actor | GCP | Medical University of Graz |
| Austria | Public Actor | Phase II-III | Medical University of Graz |
| Austria | Public Actor | Phase IV | Medical University of Graz |
| Austria | Public Actor | Quality | Medical University of Graz |
| Austria | National Competent Authority | Assistance in clinical trial application | BASG / AGES |
| Austria | National Competent Authority | Non-clinical | BASG / AGES |
| Austria | National Competent Authority | Phase I | BASG / AGES |
| Austria | National Competent Authority | Phase II-III | BASG / AGES |
| Austria | National Competent Authority | Phase IV | BASG / AGES |
| Austria | National Competent Authority | Pre-clinical | BASG / AGES |
| Austria | National Competent Authority | Quality | BASG / AGES |
| Belgium | Public Actor | GMP | University of Liège |
| Belgium | Public Actor | Quality | University of Liège |
| Belgium | Public Actor | GCP | UZ Brussel |
| Belgium | Public Actor | Phase I | UZ Brussel |
| Belgium | Public Actor | Phase II-III | UZ Brussel |
| Belgium | Public Actor | Assistance in clinical trial application | Antwerp University Hospital |
| Belgium | Public Actor | GCP | Antwerp University Hospital |
| Belgium | Public Actor | Phase I | Antwerp University Hospital |
| Belgium | Public Actor | Phase II-III | Antwerp University Hospital |
| Belgium | Public Actor | Phase IV | Antwerp University Hospital |
| Belgium | Public Actor | Pre-grant advice | Antwerp University Hospital |
| Belgium | Public Actor | Quality | Antwerp University Hospital |
| Belgium | National Competent Authority | GCP | FAMHP |
| Belgium | National Competent Authority | GLP | FAMHP |
| Belgium | National Competent Authority | GMP | FAMHP |
| Belgium | National Competent Authority | Non-clinical | FAMHP |
| Belgium | National Competent Authority | Phase I | FAMHP |
| Belgium | National Competent Authority | Phase II-III | FAMHP |
| Belgium | National Competent Authority | Phase IV | FAMHP |
| Belgium | National Competent Authority | Pre-clinical | FAMHP |
| Belgium | National Competent Authority | Quality | FAMHP |
| Croatia | Public Actor | GLP | University Hospital Center Zagreb |
| Croatia | Public Actor | Phase II-III | University Hospital Center Zagreb |
| Croatia | Public Actor | Phase IV | University Hospital Center Zagreb |
| Croatia | Public Actor | Pre-grant advice | University Hospital Center Zagreb |
| Croatia | Public Actor | Quality | University Hospital Center Zagreb |
| Croatia | National Competent Authority | GMP | HALMED |
| Croatia | National Competent Authority | Non-clinical | HALMED |
| Croatia | National Competent Authority | Phase I | HALMED |
| Croatia | National Competent Authority | Phase II-III | HALMED |
| Croatia | National Competent Authority | Phase IV | HALMED |
| Croatia | National Competent Authority | Pre-clinical | HALMED |
| Croatia | National Competent Authority | Pre-grant advice | HALMED |
| Croatia | National Competent Authority | Quality | HALMED |
| Czech Republic | Public Actor | Assistance in clinical trial application | University Hospital Hradec Králové |
| Czech Republic | Public Actor | GCP | University Hospital Hradec Králové |
| Czech Republic | Public Actor | Non-clinical | University Hospital Hradec Králové |
| Czech Republic | Public Actor | Phase II-III | University Hospital Hradec Králové |
| Czech Republic | Public Actor | Phase IV | University Hospital Hradec Králové |
| Czech Republic | Public Actor | Pre-grant advice | University Hospital Hradec Králové |
| Czech Republic | Public Actor | GCP | PharmAround |
| Czech Republic | Public Actor | GMP | PharmAround |
| Czech Republic | Public Actor | Non-clinical | PharmAround |
| Czech Republic | Public Actor | Phase I | PharmAround |
| Czech Republic | Public Actor | Phase II-III | PharmAround |
| Czech Republic | Public Actor | Phase IV | PharmAround |
| Czech Republic | Public Actor | Quality | PharmAround |
| Czech Republic | Public Actor | Assistance in clinical trial application | Czech Clinical Research Infrastructure Network |
| Czech Republic | Public Actor | GCP | Czech Clinical Research Infrastructure Network |
| Czech Republic | Public Actor | GLP | Czech Clinical Research Infrastructure Network |
| Czech Republic | Public Actor | GMP | Czech Clinical Research Infrastructure Network |
| Czech Republic | Public Actor | Phase I | Czech Clinical Research Infrastructure Network |
| Czech Republic | Public Actor | Phase II-III | Czech Clinical Research Infrastructure Network |
| Czech Republic | Public Actor | Phase IV | Czech Clinical Research Infrastructure Network |
| Czech Republic | Public Actor | Pre-grant advice | Czech Clinical Research Infrastructure Network |
| Czech Republic | Public Actor | Quality | Czech Clinical Research Infrastructure Network |
| Czech Republic | National Competent Authority | Assistance in clinical trial application | SUKL |
| Czech Republic | National Competent Authority | GCP | SUKL |
| Czech Republic | National Competent Authority | GLP | SUKL |
| Czech Republic | National Competent Authority | GMP | SUKL |
| Czech Republic | National Competent Authority | Non-clinical | SUKL |
| Czech Republic | National Competent Authority | Phase I | SUKL |
| Czech Republic | National Competent Authority | Phase II-III | SUKL |
| Czech Republic | National Competent Authority | Phase IV | SUKL |
| Czech Republic | National Competent Authority | Pre-clinical | SUKL |
| Czech Republic | National Competent Authority | Quality | SUKL |
| Estonia | Public Actor | Assistance in clinical trial application | University of Tartu |
| Estonia | Public Actor | GCP | University of Tartu |
| Estonia | Public Actor | Phase I | University of Tartu |
| Estonia | Public Actor | Phase II-III | University of Tartu |
| Estonia | Public Actor | Phase IV | University of Tartu |
| Estonia | Public Actor | Pre-grant advice | University of Tartu |
| Estonia | Public Actor | Quality | University of Tartu |
| Estonia | Public Actor | Assistance in clinical trial application | North Estonia Medical Center |
| Estonia | Public Actor | GCP | North Estonia Medical Center |
| Estonia | Public Actor | GLP | North Estonia Medical Center |
| Estonia | Public Actor | GMP | North Estonia Medical Center |
| Estonia | Public Actor | Phase I | North Estonia Medical Center |
| Estonia | Public Actor | Phase II-III | North Estonia Medical Center |
| Estonia | Public Actor | Phase IV | North Estonia Medical Center |
| Estonia | Public Actor | Quality | North Estonia Medical Center |
| Europe | Public Actor | GCP | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Europe | Public Actor | Phase I | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Europe | Public Actor | Phase II-III | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Europe | Public Actor | Phase IV | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Europe | Public Actor | Pre-grant advice | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Europe | Public Actor | Assistance in clinical trial application | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Europe | Public Actor | GCP | MRC Regulatory Support Centre |
| Europe | Public Actor | Non-clinical | MRC Regulatory Support Centre |
| Europe | Public Actor | Phase I | MRC Regulatory Support Centre |
| Europe | Public Actor | Phase II-III | MRC Regulatory Support Centre |
| Europe | Public Actor | Phase IV | MRC Regulatory Support Centre |
| Europe | Public Actor | Pre-grant advice | MRC Regulatory Support Centre |
| Europe | Public Actor | Quality | MRC Regulatory Support Centre |
| Europe | Public Actor | Assistance in clinical trial application | EVICR.net |
| Europe | Public Actor | GCP | EVICR.net |
| Europe | Public Actor | Phase I | EVICR.net |
| Europe | Public Actor | Phase II-III | EVICR.net |
| Europe | Public Actor | Phase IV | EVICR.net |
| Europe | Public Actor | Pre-grant advice | EVICR.net |
| Europe | Public Actor | Quality | EVICR.net |
| Europe | Public Actor | Assistance in clinical trial application | EATRIS |
| Europe | Public Actor | GCP | EATRIS |
| Europe | Public Actor | GLP | EATRIS |
| Europe | Public Actor | GMP | EATRIS |
| Europe | Public Actor | Non-clinical | EATRIS |
| Europe | Public Actor | Phase I | EATRIS |
| Europe | Public Actor | Phase II-III | EATRIS |
| Europe | Public Actor | Phase IV | EATRIS |
| Europe | Public Actor | Pre-clinical | EATRIS |
| Europe | Public Actor | Quality | EATRIS |
| Europe | Public Actor | Pre-grant advice | EATRIS |
| Europe | Public Actor | GCP | Research Quality Association |
| Europe | Public Actor | GLP | Research Quality Association |
| Europe | Public Actor | GMP | Research Quality Association |
| Europe | Public Actor | Non-clinical | Research Quality Association |
| Europe | Public Actor | Phase I | Research Quality Association |
| Europe | Public Actor | Phase II-III | Research Quality Association |
| Europe | Public Actor | Phase IV | Research Quality Association |
| Europe | Public Actor | Pre-clinical | Research Quality Association |
| Europe | Public Actor | Quality | Research Quality Association |
| Europe | Private Actor | Assistance in clinical trial application | Pharmahungary |
| Europe | Private Actor | GCP | Pharmahungary |
| Europe | Private Actor | Non-clinical | Pharmahungary |
| Europe | Private Actor | Phase I | Pharmahungary |
| Europe | Private Actor | Phase II-III | Pharmahungary |
| Europe | Private Actor | Phase IV | Pharmahungary |
| Europe | Private Actor | Pre-clinical | Pharmahungary |
| Europe | Private Actor | Pre-grant advice | Pharmahungary |
| Europe | Public Actor | GLP | European Centre for Clinical Research Training |
| Europe | Public Actor | GCP | European Centre for Clinical Research Training |
| Europe | Public Actor | GMP | European Centre for Clinical Research Training |
| Europe | Public Actor | Phase I | European Centre for Clinical Research Training |
| Europe | Public Actor | Phase II-III | European Centre for Clinical Research Training |
| Europe | Public Actor | Phase IV | European Centre for Clinical Research Training |
| Europe | Public Actor | Pre-clinical | European Centre for Clinical Research Training |
| Europe | Public Actor | Quality | European Centre for Clinical Research Training |
| Europe | Public Actor | Assistance in clinical trial application | HRB Clinical Research Facility Galway |
| Europe | Public Actor | GCP | HRB Clinical Research Facility Galway |
| Europe | Public Actor | Phase I | HRB Clinical Research Facility Galway |
| Europe | Public Actor | Phase II-III | HRB Clinical Research Facility Galway |
| Europe | Public Actor | Phase IV | HRB Clinical Research Facility Galway |
| Europe | Public Actor | Pre-grant advice | HRB Clinical Research Facility Galway |
| Europe | Public Actor | Quality | HRB Clinical Research Facility Galway |
| Europe | Public Actor | Assistance in clinical trial application | European Forum for Good Clinical Practice |
| Europe | Public Actor | GCP | European Forum for Good Clinical Practice |
| Europe | Public Actor | GLP | European Forum for Good Clinical Practice |
| Europe | Public Actor | GMP | European Forum for Good Clinical Practice |
| Europe | Public Actor | Phase I | European Forum for Good Clinical Practice |
| Europe | Public Actor | Phase II-III | European Forum for Good Clinical Practice |
| Europe | Public Actor | Phase IV | European Forum for Good Clinical Practice |
| Europe | Public Actor | Quality | European Forum for Good Clinical Practice |
| Europe | Public Actor | Assistance in clinical trial application | European Clinical Research Infrastructure Network |
| Europe | Public Actor | GCP | European Clinical Research Infrastructure Network |
| Europe | Public Actor | Phase I | European Clinical Research Infrastructure Network |
| Europe | Public Actor | Phase II-III | European Clinical Research Infrastructure Network |
| Europe | Public Actor | Phase IV | European Clinical Research Infrastructure Network |
| Europe | Public Actor | Pre-grant advice | European Clinical Research Infrastructure Network |
| Europe | Public Actor | Quality | European Clinical Research Infrastructure Network |
| Europe | Public Actor | Assistance in clinical trial application | Institute for Interdisciplinary Innovation in healthcare |
| Europe | Public Actor | GCP | Institute for Interdisciplinary Innovation in healthcare |
| Europe | Public Actor | GLP | Institute for Interdisciplinary Innovation in healthcare |
| Europe | Public Actor | GMP | Institute for Interdisciplinary Innovation in healthcare |
| Europe | Public Actor | Non-clinical | Institute for Interdisciplinary Innovation in healthcare |
| Europe | Public Actor | Phase I | Institute for Interdisciplinary Innovation in healthcare |
| Europe | Public Actor | Phase II-III | Institute for Interdisciplinary Innovation in healthcare |
| Europe | Public Actor | Phase IV | Institute for Interdisciplinary Innovation in healthcare |
| Europe | Public Actor | Pre-clinical | Institute for Interdisciplinary Innovation in healthcare |
| Europe | Public Actor | Pre-grant advice | Institute for Interdisciplinary Innovation in healthcare |
| Europe | Public Actor | Quality | Institute for Interdisciplinary Innovation in healthcare |
| Europe | Public Actor | Assistance in clinical trial application | International Clinical Trial Center Network |
| Europe | Public Actor | GCP | International Clinical Trial Center Network |
| Europe | Public Actor | Non-clinical | International Clinical Trial Center Network |
| Europe | Public Actor | Phase I | International Clinical Trial Center Network |
| Europe | Public Actor | Phase II-III | International Clinical Trial Center Network |
| Europe | Public Actor | Phase IV | International Clinical Trial Center Network |
| Europe | Public Actor | Pediatric studies | International Clinical Trial Center Network |
| Europe | Public Actor | Quality | International Clinical Trial Center Network |
| Finland | Public Actor | Pre-clinical | University of Eastern Finland |
| Finland | Public Actor | Pre-grant advice | University of Eastern Finland |
| Finland | Public Actor | Quality | University of Eastern Finland |
| Finland | Public Actor | GCP | Northern Savo Hospital District Municipal Federation |
| Finland | Public Actor | Phase I | Northern Savo Hospital District Municipal Federation |
| Finland | Public Actor | Phase II-III | Northern Savo Hospital District Municipal Federation |
| Finland | Public Actor | Phase IV | Northern Savo Hospital District Municipal Federation |
| Finland | National Competent Authority | Assistance in clinical trial application | FIMEA |
| Finland | National Competent Authority | GCP | FIMEA |
| Finland | National Competent Authority | GLP | FIMEA |
| Finland | National Competent Authority | GMP | FIMEA |
| Finland | National Competent Authority | Non-clinical | FIMEA |
| Finland | National Competent Authority | Phase I | FIMEA |
| Finland | National Competent Authority | Phase II-III | FIMEA |
| Finland | National Competent Authority | Phase IV | FIMEA |
| Finland | National Competent Authority | Pre-clinical | FIMEA |
| Finland | National Competent Authority | Quality | FIMEA |
| France | Public Actor | Assistance in clinical trial application | CHU Grenoble Alpes |
| France | Public Actor | GCP | CHU Grenoble Alpes |
| France | Public Actor | Phase I | CHU Grenoble Alpes |
| France | Public Actor | Phase II-III | CHU Grenoble Alpes |
| France | Public Actor | Phase IV | CHU Grenoble Alpes |
| France | Public Actor | Quality | CHU Grenoble Alpes |
| France | Public Actor | Assistance in clinical trial application | AP-HP |
| France | Public Actor | GCP | AP-HP |
| France | Public Actor | Phase I | AP-HP |
| France | Public Actor | Phase II-III | AP-HP |
| France | Public Actor | Phase IV | AP-HP |
| France | Public Actor | Pre-grant advice | AP-HP |
| France | Public Actor | Quality | AP-HP |
| France | Public Actor | Assistance in clinical trial application | Rothschild Foundation Hospital |
| France | Public Actor | Phase II-III | Rothschild Foundation Hospital |
| France | Public Actor | Phase IV | Rothschild Foundation Hospital |
| France | Public Actor | Pre-grant advice | Rothschild Foundation Hospital |
| France | Public Actor | Assistance in clinical trial application | CHU Amiens Picardie |
| France | Public Actor | GCP | CHU Amiens Picardie |
| France | Public Actor | Phase I | CHU Amiens Picardie |
| France | Public Actor | Phase II-III | CHU Amiens Picardie |
| France | Public Actor | Phase IV | CHU Amiens Picardie |
| France | Public Actor | Pre-grant advice | CHU Amiens Picardie |
| Germany | Public Actor | GCP | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Germany | Public Actor | Phase I | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Germany | Public Actor | Phase II-III | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Germany | Public Actor | Phase IV | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Germany | Public Actor | Pre-grant advice | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Germany | Public Actor | Assistance in clinical trial application | Coordination Centre for Clinical Trials (KKS) Heidelberg |
| Germany | Public Actor | Assistance in clinical trial application | Technical University Munich |
| Germany | Public Actor | GCP | Technical University Munich |
| Germany | Public Actor | Phase I | Technical University Munich |
| Germany | Public Actor | Phase II-III | Technical University Munich |
| Germany | Public Actor | Phase IV | Technical University Munich |
| Germany | Public Actor | Pre-grant advice | Technical University Munich |
| Germany | Public Actor | Quality | Technical University Munich |
| Germany | Public Actor | Assistance in clinical trial application | Center for Clinical Trials Tuebingen |
| Germany | Public Actor | GCP | Center for Clinical Trials Tuebingen |
| Germany | Public Actor | Phase I | Center for Clinical Trials Tuebingen |
| Germany | Public Actor | Phase II-III | Center for Clinical Trials Tuebingen |
| Germany | Public Actor | Phase IV | Center for Clinical Trials Tuebingen |
| Germany | Public Actor | Assistance in clinical trial application | Medical University Innsbruck |
| Germany | Public Actor | GCP | Medical University Innsbruck |
| Germany | Public Actor | Phase I | Medical University Innsbruck |
| Germany | Public Actor | Phase II-III | Medical University Innsbruck |
| Germany | Public Actor | Phase IV | Medical University Innsbruck |
| Germany | Public Actor | Assistance in clinical trial application | Clinical Trial Centre Leipzig |
| Germany | Public Actor | GCP | Clinical Trial Centre Leipzig |
| Germany | Public Actor | Phase II-III | Clinical Trial Centre Leipzig |
| Germany | Public Actor | Phase IV | Clinical Trial Centre Leipzig |
| Germany | Public Actor | Pre-grant advice | Clinical Trial Centre Leipzig |
| Germany | Public Actor | Assistance in clinical trial application | The Philipps University Marburg |
| Germany | Public Actor | GCP | The Philipps University Marburg |
| Germany | Public Actor | Phase I | The Philipps University Marburg |
| Germany | Public Actor | Phase II-III | The Philipps University Marburg |
| Germany | Public Actor | Pre-grant advice | The Philipps University Marburg |
| Germany | Public Actor | Assistance in clinical trial application | Association for Applied Human Pharmacology |
| Germany | Public Actor | GCP | Association for Applied Human Pharmacology |
| Germany | Public Actor | GLP | Association for Applied Human Pharmacology |
| Germany | Public Actor | GMP | Association for Applied Human Pharmacology |
| Germany | Public Actor | Non-clinical | Association for Applied Human Pharmacology |
| Germany | Public Actor | Phase I | Association for Applied Human Pharmacology |
| Germany | Public Actor | Phase II-III | Association for Applied Human Pharmacology |
| Germany | Public Actor | Pre-grant advice | Association for Applied Human Pharmacology |
| Germany | Public Actor | Quality | Association for Applied Human Pharmacology |
| Germany | Public Actor | Assistance in clinical trial application | Network of Coordinating Centers for Clinical Trials |
| Germany | Public Actor | GCP | Network of Coordinating Centers for Clinical Trials |
| Germany | Public Actor | Phase I | Network of Coordinating Centers for Clinical Trials |
| Germany | Public Actor | Phase II-III | Network of Coordinating Centers for Clinical Trials |
| Germany | Public Actor | Phase IV | Network of Coordinating Centers for Clinical Trials |
| Germany | Public Actor | GCP | SZB - Clinical Study Core Unit Bonn |
| Germany | Public Actor | Quality | SZB - Clinical Study Core Unit Bonn |
| Germany | Public Actor | Phase I | SZB - Clinical Study Core Unit Bonn |
| Germany | Public Actor | Phase II-III | SZB - Clinical Study Core Unit Bonn |
| Germany | Public Actor | Phase IV | SZB - Clinical Study Core Unit Bonn |
| Germany | Public Actor | Assistance in pre-grant advice | SZB - Clinical Study Core Unit Bonn |
| Germany | Public Actor | Assistance in clinical trial application | SZB - Clinical Study Core Unit Bonn |
| Germany | National Competent Authority | Assistance in clinical trial application | BfArM |
| Germany | National Competent Authority | GCP | BfArM |
| Germany | National Competent Authority | GMP | BfArM |
| Germany | National Competent Authority | Non-clinical | BfArM |
| Germany | National Competent Authority | Phase I | BfArM |
| Germany | National Competent Authority | Phase II-III | BfArM |
| Germany | National Competent Authority | Phase IV | BfArM |
| Germany | National Competent Authority | Pre-clinical | BfArM |
| Germany | National Competent Authority | Assistance in pre-grant advice | BfArM |
| Germany | National Competent Authority | Quality | BfArM |
| Germany | National Competent Authority | GPC | Paul Ehrlich Institut |
| Germany | National Competent Authority | Non-clinical | Paul Ehrlich Institut |
| Germany | National Competent Authority | Quality | Paul Ehrlich Institut |
| Germany | National Competent Authority | Pre-clinical | Paul Ehrlich Institut |
| Germany | National Competent Authority | Phase I | Paul Ehrlich Institut |
| Germany | National Competent Authority | Phase II-III | Paul Ehrlich Institut |
| Germany | National Competent Authority | Phase IV | Paul Ehrlich Institut |
| Germany | National Competent Authority | Assistance in pre-grant advice | Paul Ehrlich Institut |
| Germany | National Competent Authority | Assistance in Clinical Trial Application | Paul Ehrlich Institut |
| Hungary | Public Actor | GCP | Semmelweis University |
| Hungary | Public Actor | Phase I | Semmelweis University |
| Hungary | Public Actor | Phase II-III | Semmelweis University |
| Hungary | Public Actor | Phase IV | Semmelweis University |
| Hungary | Public Actor | Pre-clinical | Semmelweis University |
| Hungary | Public Actor | GCP | University of Pécs Coordination Center for Clinical Trials |
| Hungary | Public Actor | Phase II-III | University of Pécs Coordination Center for Clinical Trials |
| Hungary | Public Actor | Quality | University of Pécs Coordination Center for Clinical Trials |
| Hungary | National Competent Authority | Assistance in clinical trial application | OGYÉI |
| Hungary | National Competent Authority | GLP | OGYÉI |
| Hungary | National Competent Authority | GMP | OGYÉI |
| Hungary | National Competent Authority | Non-clinical | OGYÉI |
| Hungary | National Competent Authority | Phase I | OGYÉI |
| Hungary | National Competent Authority | Phase II-III | OGYÉI |
| Hungary | National Competent Authority | Phase IV | OGYÉI |
| Hungary | National Competent Authority | Pre-clinical | OGYÉI |
| Hungary | National Competent Authority | Quality | OGYÉI |
| Ireland | Public Actor | GCP | University College Cork |
| Ireland | Public Actor | Phase II-III | University College Cork |
| Ireland | Public Actor | Phase IV | University College Cork |
| Ireland | Public Actor | Quality | University College Cork |
| Ireland | Public Actor | Assistance in clinical trial application | Royal College of Surgeons in Ireland |
| Ireland | Public Actor | GCP | Royal College of Surgeons in Ireland |
| Ireland | Public Actor | Phase II-III | Royal College of Surgeons in Ireland |
| Ireland | Public Actor | Phase IV | Royal College of Surgeons in Ireland |
| Ireland | Public Actor | Pre-grant advice | Royal College of Surgeons in Ireland |
| Ireland | Public Actor | Quality | Royal College of Surgeons in Ireland |
| Ireland | Public Actor | Assistance in clinical trial application | Health Research Board Clinical Research Coordination Ireland |
| Ireland | Public Actor | GCP | Health Research Board Clinical Research Coordination Ireland |
| Ireland | Public Actor | Phase I | Health Research Board Clinical Research Coordination Ireland |
| Ireland | Public Actor | Phase II-III | Health Research Board Clinical Research Coordination Ireland |
| Ireland | Public Actor | Phase IV | Health Research Board Clinical Research Coordination Ireland |
| Ireland | Public Actor | Pre-grant advice | Health Research Board Clinical Research Coordination Ireland |
| Ireland | Public Actor | Quality | Health Research Board Clinical Research Coordination Ireland |
| Ireland | Public Actor | Assistance in clinical trial application | Cancer Trials Ireland |
| Ireland | Public Actor | GCP | Cancer Trials Ireland |
| Ireland | Public Actor | Phase II-III | Cancer Trials Ireland |
| Ireland | Public Actor | Quality | Cancer Trials Ireland |
| Ireland | National Competent Authority | Assistance in clinical trial application | HPRA |
| Ireland | National Competent Authority | GCP | HPRA |
| Ireland | National Competent Authority | GLP | HPRA |
| Ireland | National Competent Authority | GMP | HPRA |
| Ireland | National Competent Authority | Non-clinical | HPRA |
| Ireland | National Competent Authority | Phase I | HPRA |
| Ireland | National Competent Authority | Phase II-III | HPRA |
| Ireland | National Competent Authority | Phase IV | HPRA |
| Ireland | National Competent Authority | Pre-clinical | HPRA |
| Ireland | National Competent Authority | Quality | HPRA |
| Italy | Public Actor | Assistance in clinical trial application | Sant’Orsola-Malpighi Hospital Bologna |
| Italy | Public Actor | GCP | Sant’Orsola-Malpighi Hospital Bologna |
| Italy | Public Actor | GMP | Sant’Orsola-Malpighi Hospital Bologna |
| Italy | Public Actor | Phase I | Sant’Orsola-Malpighi Hospital Bologna |
| Italy | Public Actor | Phase II-III | Sant’Orsola-Malpighi Hospital Bologna |
| Italy | Public Actor | Phase IV | Sant’Orsola-Malpighi Hospital Bologna |
| Italy | Public Actor | Pre-clinical | Sant’Orsola-Malpighi Hospital Bologna |
| Italy | Public Actor | Quality | Sant’Orsola-Malpighi Hospital Bologna |
| Italy | Public Actor | GCP | Istituto Europeo di Oncologia |
| Italy | Public Actor | Phase I | Istituto Europeo di Oncologia |
| Italy | Public Actor | Phase II-III | Istituto Europeo di Oncologia |
| Italy | Public Actor | Quality | Istituto Europeo di Oncologia |
| Italy | Public Actor | Assistance in clinical trial application | Istituto Nazionale Tumori |
| Italy | Public Actor | GCP | Istituto Nazionale Tumori |
| Italy | Public Actor | Phase I | Istituto Nazionale Tumori |
| Italy | Public Actor | Phase II-III | Istituto Nazionale Tumori |
| Italy | Public Actor | Phase IV | Istituto Nazionale Tumori |
| Italy | Public Actor | Quality | Istituto Nazionale Tumori |
| Latvia | Public Actor | Non-clinical | University of Latvia |
| Latvia | Public Actor | Pre-clinical | University of Latvia |
| Latvia | Public Actor | Phase II-III | University of Latvia |
| Latvia | Public Actor | Pre-grant advice | University of Latvia |
| Latvia | Public Actor | Assistance in clinical trial application | Pauls Stradins Clinical University Hospital |
| Latvia | Public Actor | GCP | Pauls Stradins Clinical University Hospital |
| Latvia | Public Actor | Phase I | Pauls Stradins Clinical University Hospital |
| Latvia | Public Actor | Phase II-III | Pauls Stradins Clinical University Hospital |
| Latvia | Public Actor | Phase II-III | Pauls Stradins Clinical University Hospital |
| Latvia | Public Actor | Phase II-III | Pauls Stradins Clinical University Hospital |
| Latvia | Public Actor | Phase II-III | Pauls Stradins Clinical University Hospital |
| Latvia | Public Actor | Phase II-III | Pauls Stradins Clinical University Hospital |
| Latvia | Public Actor | Phase II-III | Pauls Stradins Clinical University Hospital |
| Latvia | Public Actor | Phase II-III | Pauls Stradins Clinical University Hospital |
| Latvia | Public Actor | Phase IV | Pauls Stradins Clinical University Hospital |
| Malta | National Competent Authority | Assistance in clinical trial application | Medicines Authority |
| Malta | National Competent Authority | GMP | Medicines Authority |
| Malta | National Competent Authority | Phase I | Medicines Authority |
| Malta | National Competent Authority | Phase II-III | Medicines Authority |
| Malta | National Competent Authority | Phase IV | Medicines Authority |
| Malta | National Competent Authority | Pre-clinical | Medicines Authority |
| Malta | National Competent Authority | Quality | Medicines Authority |
| Netherlands | National Competent Authority | Assistance in clinical trial application | Medicines Evaluation Board |
| Netherlands | National Competent Authority | Non-clinical | Medicines Evaluation Board |
| Netherlands | National Competent Authority | Phase I | Medicines Evaluation Board |
| Netherlands | National Competent Authority | Phase II-III | Medicines Evaluation Board |
| Netherlands | National Competent Authority | Phase IV | Medicines Evaluation Board |
| Netherlands | National Competent Authority | Pre-clinical | Medicines Evaluation Board |
| Netherlands | National Competent Authority | Quality | Medicines Evaluation Board |
| Netherlands | Public Actor | Non-clinical | Pauls Stradins Clinical University Hospital |
| Netherlands | Public Actor | GCP | Regulatory Science Network Netherlands |
| Netherlands | Public Actor | Non-clinical | Regulatory Science Network Netherlands |
| Netherlands | Public Actor | Phase I | Regulatory Science Network Netherlands |
| Netherlands | Public Actor | Phase II-III | Regulatory Science Network Netherlands |
| Netherlands | Public Actor | Phase IV | Regulatory Science Network Netherlands |
| Netherlands | Public Actor | Pre-clinical | Regulatory Science Network Netherlands |
| Netherlands | Public Actor | Quality | Regulatory Science Network Netherlands |
| Norway | National Competent Authority | Assistance in clinical trial application | Norwegian Medicines Agency |
| Norway | National Competent Authority | GCP | Norwegian Medicines Agency |
| Norway | National Competent Authority | GMP | Norwegian Medicines Agency |
| Norway | National Competent Authority | Non-clinical | Norwegian Medicines Agency |
| Norway | National Competent Authority | Phase I | Norwegian Medicines Agency |
| Norway | National Competent Authority | Phase II-III | Norwegian Medicines Agency |
| Norway | National Competent Authority | Phase IV | Norwegian Medicines Agency |
| Norway | National Competent Authority | Pre-clinical | Norwegian Medicines Agency |
| Norway | National Competent Authority | Quality | Norwegian Medicines Agency |
| Portugal | National Competent Agency | GLP | Inframed IP |
| Portugal | National Competent Agency | GCP | Inframed IP |
| Portugal | National Competent Agency | GMP | Inframed IP |
| Portugal | National Competent Agency | Non-clinical | Inframed IP |
| Portugal | National Competent Agency | Quality | Inframed IP |
| Portugal | National Competent Agency | Pre-clinical | Inframed IP |
| Portugal | National Competent Agency | Phase I | Inframed IP |
| Portugal | National Competent Agency | Phase II-III | Inframed IP |
| Portugal | National Competent Agency | Phase IV | Inframed IP |
| Portugal | National Competent Agency | Assistance in pre-grant advice | Inframed IP |
| Portugal | National Competent Agency | Assistance in clinical trial application | Inframed IP |
| Portugal | Public Actor | Assistance in clinical trial application | 2CA-Braga |
| Portugal | Public Actor | GCP | 2CA-Braga |
| Portugal | Public Actor | Phase I | 2CA-Braga |
| Portugal | Public Actor | Phase II-III | 2CA-Braga |
| Portugal | Public Actor | Assistance in clinical trial application | Portuguese Oncology Institute |
| Portugal | Public Actor | GCP | Portuguese Oncology Institute |
| Portugal | Public Actor | Phase I | Portuguese Oncology Institute |
| Portugal | Public Actor | Phase II-III | Portuguese Oncology Institute |
| Portugal | Public Actor | Quality | Portuguese Oncology Institute |
| Slovakia | Public Actor | Assistance in clinical trial application | Pavol Jozef Safarik University in Kosice |
| Slovakia | Public Actor | GCP | Pavol Jozef Safarik University in Kosice |
| Slovakia | Public Actor | Phase I | Pavol Jozef Safarik University in Kosice |
| Slovakia | Public Actor | Phase II-III | Pavol Jozef Safarik University in Kosice |
| Slovakia | Public Actor | Phase IV | Pavol Jozef Safarik University in Kosice |
| Slovakia | Public Actor | Quality | Pavol Jozef Safarik University in Kosice |
| Spain | Public Actor | Assistance in clinical trial application | RECLIP |
| Spain | Public Actor | GCP | RECLIP |
| Spain | Public Actor | Phase I | RECLIP |
| Spain | Public Actor | Phase II-III | RECLIP |
| Spain | Public Actor | Phase IV | RECLIP |
| Spain | Public Actor | Pre-clinical | CIBER |
| Spain | Public Actor | Assistance in clinical trial application | Vall d’Hebron Research Institut |
| Spain | Public Actor | GCP | Vall d’Hebron Research Institut |
| Spain | Public Actor | Phase I | Vall d’Hebron Research Institut |
| Spain | Public Actor | Phase II-III | Vall d’Hebron Research Institut |
| Spain | Public Actor | Phase IV | Vall d’Hebron Research Institut |
| Spain | Public Actor | Pre-grant advice | Vall d’Hebron Research Institut |
| Spain | National Competent Authority | Assistance in clinical trial application | AEMPS |
| Spain | National Competent Authority | GCP | AEMPS |
| Spain | National Competent Authority | GLP | AEMPS |
| Spain | National Competent Authority | GMP | AEMPS |
| Spain | National Competent Authority | Non-clinical | AEMPS |
| Spain | National Competent Authority | Phase I | AEMPS |
| Spain | National Competent Authority | Phase II-III | AEMPS |
| Spain | National Competent Authority | Phase IV | AEMPS |
| Spain | National Competent Authority | Pre-clinical | AEMPS |
| Spain | National Competent Authority | Pre-grant advice | AEMPS |
| Spain | National Competent Authority | Quality | AEMPS |
| Sweden | National Competent Authority | Assistance in clinical trial application | Swedish Medical Products Agency |
| Sweden | National Competent Authority | GCP | Swedish Medical Products Agency |
| Sweden | National Competent Authority | Non-clinical | Swedish Medical Products Agency |
| Sweden | National Competent Authority | Phase I | Swedish Medical Products Agency |
| Sweden | National Competent Authority | Phase II-III | Swedish Medical Products Agency |
| Sweden | National Competent Authority | Pre-clinical | Swedish Medical Products Agency |
| Sweden | National Competent Authority | Pre-grand-advice | Swedish Medical Products Agency |
| Sweden | National Competent Authority | Quality | Swedish Medical Products Agency |
| Switzerland | Public Actor | Assistance in clinical trial application | Medical University Innsbruck |
| Switzerland | Public Actor | GCP | Medical University Innsbruck |
| Switzerland | Public Actor | Phase I | Medical University Innsbruck |
| Switzerland | Public Actor | Phase II-III | Medical University Innsbruck |
| Switzerland | Public Actor | Phase IV | Medical University Innsbruck |
| Switzerland | Public Actor | Assistance in clinical trial application | Clinical Trails Center Zurich |
| Switzerland | Public Actor | GCP | Clinical Trails Center Zurich |
| Switzerland | Public Actor | Non-clinical | Clinical Trails Center Zurich |
| Switzerland | Public Actor | Phase I | Clinical Trails Center Zurich |
| Switzerland | Public Actor | Phase II-III | Clinical Trails Center Zurich |
| Switzerland | Public Actor | Phase IV | Clinical Trails Center Zurich |
| Switzerland | Public Actor | Pre-clinical | Clinical Trails Center Zurich |
| Switzerland | Public Actor | Quality | Clinical Trails Center Zurich |
| UK | National Competent Authority | GCP | MHRA innovation office |
| UK | National Competent Authority | GLP | MHRA innovation office |
| UK | National Competent Authority | GMP | MHRA innovation office |
| UK | National Competent Authority | Non-clinical | MHRA innovation office |
| UK | National Competent Authority | Phase I | MHRA innovation office |
| UK | National Competent Authority | Phase II-III | MHRA innovation office |
| UK | National Competent Authority | Phase IV | MHRA innovation office |
| UK | National Competent Authority | Pre-clinical | MHRA innovation office |
| UK | National Competent Authority | Pre-grant advice | MHRA innovation office |
| UK | National Competent Authority | Quality | MHRA innovation office |
| UK | Public Actor | Assistance in clinical trial application | University of Oxford |
| UK | Public Actor | GCP | University of Oxford |
| UK | Public Actor | Phase I | University of Oxford |
| UK | Public Actor | Phase II-III | University of Oxford |
| UK | Public Actor | Phase IV | University of Oxford |
| UK | Public Actor | Quality | University of Oxford |
| UK | Public Actor | Assistance in clinical trial application | The Newcastle upon Tyne Hospitals NHS Foundation Trust |
| UK | Public Actor | GCP | The Newcastle upon Tyne Hospitals NHS Foundation Trust |
| UK | Public Actor | Non-clinical | The Newcastle upon Tyne Hospitals NHS Foundation Trust |
| UK | Public Actor | Pediatric studies | The Newcastle upon Tyne Hospitals NHS Foundation Trust |
| UK | Public Actor | Phase I | The Newcastle upon Tyne Hospitals NHS Foundation Trust |
| UK | Public Actor | Phase II-III | The Newcastle upon Tyne Hospitals NHS Foundation Trust |
| UK | Public Actor | Phase IV | The Newcastle upon Tyne Hospitals NHS Foundation Trust |
| UK | Public Actor | Pre-grant advice | The Newcastle upon Tyne Hospitals NHS Foundation Trust |
| UK | Public Actor | Quality | The Newcastle upon Tyne Hospitals NHS Foundation Trust |
About this Comprehensive Inventory
STARS has established a Comprehensive Inventory of existing support activities for regulatory Scientific Advice and Protocol Assistance in Europe. Up to know, this information has never been compiled in a single place. Surveys were used to obtain the required information.
The Inventory will be regularly updated by including new information and results from the STARS project during the whole project life cycle.
Updating and sustainability of the Comprehensive Inventory beyond the live cycle of the STARS project will be addressed and ensured. A suitable host organisation for sustaining the regular updating and the web presence of the Inventory will be identified. The regulatory network in which the STARS consortium is embedded will support the identification of the future host ensuring availability beyond the duration of the STARS project.
